|
⚲
|
| Keyboard |
| John Hamill | |
|---|---|
| Firm | |
| Address | 3805 Old Easton Road Doylestown, PA 18902 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Aprea Therapeutics Inc | 021-568049 | Executive Officer | 3.1 M of 5.8 M |
||
| Cellectar Biosciences Inc | 021-296679 | Executive Officer | 7.8 M of 7.8 M |
||
| Nephrogenex Inc | 021-251166 | Executive Officer | 5.5 M of 28.5 M |
||
| Bregal Investments Inc | |||||
| Bregal Sagemount Credit Opportunities Co-Investment Fund LP | 021-329102 | Director | 75.0 M | 42.4 M | |
| Bregal Sagemount Credit Opportunities Fund II LP | 021-329106 | Director | 93.0 M | 113.3 M | |
| Bregal Sagemount II-A LP | 021-281147 | Director | 15.0 M | ||
| Related People Network |
|---|
| Network #368 at Cellectar Biosciences Inc — files alongside 8 co-filers |